Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01585831
Other study ID # 11-0874
Secondary ID 1K23NS070337
Status Completed
Phase N/A
First received
Last updated
Start date March 2012
Est. completion date October 2017

Study information

Verified date July 2021
Source University of Colorado, Denver
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine if testosterone replacement therapy leads to changes in psychological factors and/or motor skills in adolescent males with 47,XXY (also called Klinefelter syndrome). This study will also evaluate whether certain genetic factors of the X chromosome affect the psychological or motor features of XXY/Klinefelter syndrome.


Description:

Klinefelter syndrome (47,XXY) is the most common chromosomal abnormality in humans and occurs in approximately 1 in 650 males. Testosterone deficiency develops during adolescence in the majority of individuals with XXY. However, there are no previous studies that evaluate the psychological and motor effects of testosterone replacement therapy in adolescents with XXY. The study researchers are interested in learning if testosterone therapy initiated in early puberty in XXY (KS) will lead to improvements in psychological and/or motor skills. They are also interested in learning if genetic variations of the androgen receptor gene or the parent-of-origin of the extra X chromosome influence the response to testosterone therapy. Specific psychological factors to be studied include verbal and nonverbal cognitive skills, attention, executive function (organization, problem-solving skills, inhibition), anxiety, language, self-esteem, and other behavioral factors. Motor skills to be studied include gross and fine motor skills, motor coordination, and motor planning. Participants in the study will be randomized to one of two treatment groups, receiving either testosterone gel or placebo, for 12 months. 60% of the study group will receive testosterone, and 40% will receive placebo. The research participants, parents/caregivers, and the members of the study team will be blinded to the treatment group, and will not know whether they are receiving testosterone gel or placebo treatments. The supervising endocrinologist for the study will not be blinded and will know which patients are in the testosterone and placebo groups. This will allow him to monitor results to determine if participants in the placebo group may develop a significant need for testosterone therapy during the study period. If this occurs, the patient will be switched to the testosterone group and will continue to be monitored in the study. All participants will be evaluated at the beginning of the study and at 1, 3, 6, and 12 months. Travel costs are included. Evaluations will include a combination of psychological and motor skills testing, questionnaires completed by the parent/caregiver and study participant, physical examinations, and blood draws for safety monitoring and genetic studies. Participation in the trial will last one year and includes 5 clinic visits to the eXtraordinarY Kids Clinic at Children's Hospital Colorado in Denver.


Recruitment information / eligibility

Status Completed
Enrollment 48
Est. completion date October 2017
Est. primary completion date October 2017
Accepts healthy volunteers No
Gender Male
Age group 8 Years to 18 Years
Eligibility Inclusion Criteria: - Males with 47,XXY - Participants must be in early puberty (Tanner stage II-III) - Age 8 - 18 will be considered, but eligibility will be determined by review of laboratory results, bone age X-ray, and physical examination to determine stage of puberty - All racial and ethnic groups Exclusion Criteria: - Other genetic variations of Klinefelter syndrome (48,XXXY, 48,XXYY, 49,XXXXY). The investigator has other studies for these groups and we encourage interested individuals with these disorders to contact us about other available studies. - 47,XXY plus another genetic disorder - Non-English speaking individuals (because the psychological tests are administered in English) - Participants with a medical history of blood clotting problems, blindness, deafness, or cancer

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Testosterone gel 1%
Testosterone gel will be administered on a daily basis. The gel will be dispensed in a syringe, and the specific amount of gel to be applied each day will be determined by the study endocrinologist after reviewing labs.
Placebo gel
The placebo gel will be administered on a daily basis. The gel will be dispensed in a syringe, and the specific amount of gel to be applied each day will be determined by the study endocrinologist.

Locations

Country Name City State
United States Childrens Hospital Colorado Aurora Colorado

Sponsors (4)

Lead Sponsor Collaborator
University of Colorado, Denver Children's Hospital Colorado, Colorado Clinical & Translational Sciences Institute, National Institute of Neurological Disorders and Stroke (NINDS)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change From Baseline on the Delis-Kaplan Executive Function System A collection of subtests from the Delis-Kaplan Executive Function System will be used to evaluate different domains of executive functions including planning, problem solving, fluency, inhibition, and working memory. Possible scaled scores range from 0-20 (mean of 10), with higher scores indicating better performance. The value of the change in scaled score from baseline is reported. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Bruininks-Oseretsky Test of Motor Development - 2 This test evaluates many aspects of motor functioning including fine and gross motor skills, visual motor integration, motor planning, and motor coordination. Possible scores range from 20-80, with higher scores indicating a better outcome. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Conners Parent Rating Scales: DSM Attention This questionnaire allows parents to rate many aspects of behavior including attention, hyperactivity, anxiety, social skills, and emotional lability. The range of possible scores is 0 to 100 (Mean T-score 50), with higher scores indicating a worse outcome. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Conners Parent Rating Scales: DSM Hyperactivity This questionnaire allows parents to rate many aspects of behavior including attention, hyperactivity, anxiety, social skills, and emotional lability. The range of possible scores is 0 to 100 (Mean T-score 50), with higher scores indicating a worse outcome. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Conners Parent Rating Scales: Anxiety This questionnaire allows parents to rate many aspects of behavior including attention, hyperactivity, anxiety, social skills, and emotional lability. The range of possible scores is 0 to 100 (Mean T-score 50), with higher scores indicating a worse outcome. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Conners Parent Rating Scales: Social Skills This questionnaire allows parents to rate many aspects of behavior including attention, hyperactivity, anxiety, social skills, and emotional lability. The range of possible scores is 0 to 100, with higher scores indicating a worse outcome. Visit 1 (baseline) and Visit 5 (1 year)
Primary Change From Baseline on the Conners Parent Rating Scales: Emotional Lability This questionnaire allows parents to rate many aspects of behavior including attention, hyperactivity, anxiety, social skills, and emotional lability. The range of possible scores is 0 to 100, with higher scores indicating a worse outcome. Visit 1 (baseline) and Visit 5 (1 year)
Secondary Change From Baseline on the Vineland Adaptive Behavior Scales - 2nd Edition The Vineland-2 is an interview evaluating adaptive skills in the areas of communication, daily living skills, social skills, and motor skills. Possible scores range from 20 to 160 (mean 100), with higher scores indicating a better outcome. Visit 1 (baseline) and Visit 5 (1 year)
Secondary Change From Baseline on the Wechsler Intelligence Scale for Children - Fourth Edition This standardized assessment of cognitive functioning allows for evaluation of verbal and nonverbal cognitive skills, working memory, and processing speed. Possible full scale IQ scores range from 40-180 (mean 100), with higher scores indicating a better outcome. Visit 1 (baseline) and Visit 5 (1 year)
Secondary Change From Baseline on the Comprehensive Test of Phonological Processing This standardized test evaluates reading and language skills. Possible scores range from 20-200 (Mean Standard Score 100), with higher scores indicating a better outcome. Visit 1 (baseline) and Visit 5 (1 year)
See also
  Status Clinical Trial Phase
Recruiting NCT03396562 - The eXtroardinarY Babies Study: Natural History of Health and Neurodevelopment in Infants and Young Children With Sex Chromosome Trisomy
Completed NCT02526628 - Thrombosis and Neurocognition in Klinefelter Syndrome
Completed NCT01690013 - Life Quality and Health in Patients With Klinefelter Syndrome N/A
Completed NCT01678261 - X-chromosome Inactivation, Epigenetics and the Transcriptome N/A
Completed NCT01918280 - Fertility Preservation in Cases of Klinefelter Syndrome. N/A
Completed NCT02787486 - Expanded Noninvasive Genomic Medical Assessment: The Enigma Study
Completed NCT03325647 - TESTO: Testosterone Effects on Short-Term Outcomes in Infants With XXY Phase 4
Enrolling by invitation NCT03836300 - Parent and Infant Inter(X)Action Intervention (PIXI) N/A
Recruiting NCT05498090 - Interrogating Fatty Acid Metabolism Impairment and Clinical Correlates in Males With Klinefelter Syndrome Phase 4
Completed NCT00999310 - Neuropsychologic, Neuroradiologic, Endocrinologic, and Genetic Aspects of Klinefelter Syndrome N/A
Completed NCT02408445 - Body Composition in Infants With Klinefelter Syndrome and Effects of Testosterone Treatment Phase 4
Completed NCT00896272 - Adaptation Among Adolescents and Adults With Klinefelter Syndrome
Completed NCT02723305 - Cardiometabolic Profiles of Boys With Klinefelter Syndrome
Completed NCT05581147 - Thyroid Function and Structure IN Klinefelter Syndrome
Recruiting NCT05586802 - Sex Steroids Balance for Metabolic and Reproductive Health in Klinefelter Syndrome Phase 3
Active, not recruiting NCT02430584 - Whole Blood Specimen Collection From Pregnant Subjects
Completed NCT01817296 - Klinefelter Fertility Preservation N/A
Completed NCT01206270 - Androgen for Leydig Cell Proliferation Phase 2/Phase 3
Withdrawn NCT00347464 - Adaptive Behavior Assessment of Men With 49, XXXXY, Klinefelter Syndrome N/A
Recruiting NCT05425953 - Endocrine, Metabolic, Cardiovascular and Immunological Aspects of Sex Chromosome Abnormalities in Relation to Genotype